Pressemitteilungen
Letzte Veröffentlichungen:
Milestone at Vienna General Hospital: VivaScope revolutionises cancer diagnosis and treatment in Austria
In Austria, around 42,000 people are diagnosed with cancer every year. Although this is a matter of health and therefore the greatest human good, the analogue frozen section – a technique first used in 1895 – is still considered the gold standard for intraoperative pathological assessment when removing tumour tissue. With its „Ex Vivo“ technology, the company VivaScope is bringing about a fundamental medical revolution. Thanks to digital optical sections, tumour tissue can be removed more efficiently than ever before and assessed within five minutes using telemedicine. The VivaScope 2500 is now being used for the first time in the field of dermatology at Vienna General Hospital.
New hope for people suffering from pancreatic cancer
Revolutionary study results thanks to the VivaScope 2500 laser scanning microscope.
Fluorescence Confocal Microscopy on Liver Specimens for Full Digitization of Transplant Pathology
September 2023 – Rapid evaluation of donor liver specimens for transplantation using the VivaScope® 2500 Technology
Aktuelle Publikationen in Verbindung mit unserer Technologie:
Extensive large-scale clinical trial demonstrated the therapeutic & economic value of the VivaScope 1500 In Vivo microscope in early diagnosis of Melanoma lesions
Extensive large-scale clinical trial demonstrated the therapeutic & economic value of the VivaScope 1500 In Vivo microscope in early diagnosis of Melanoma lesions
Fluorescence Confocal Microscopy on Liver Specimens for Full Digitization of Transplant Pathology
September 2023 – Rapid evaluation of donor liver specimens for transplantation using the VivaScope® 2500 Technology
Milestone at Vienna General Hospital: VivaScope revolutionises cancer diagnosis and treatment in Austria
In Austria, around 42,000 people are diagnosed with cancer every year. Although this is a matter of health and therefore the greatest human good, the analogue frozen section – a technique first used in 1895 – is still considered the gold standard for intraoperative pathological assessment when removing tumour tissue. With its „Ex Vivo“ technology, the company VivaScope is bringing about a fundamental medical revolution. Thanks to digital optical sections, tumour tissue can be removed more efficiently than ever before and assessed within five minutes using telemedicine. The VivaScope 2500 is now being used for the first time in the field of dermatology at Vienna General Hospital.